research hospital memphis hhs placed order sanofi million doses vaccine strain human trials began march preliminary results clinical trial indicate vaccine protective says niaid director anthony s. fauci hhs secretary michael leavitt trying negotiate 20 million doses adds leavitt announced september hhs increased h5n1 vaccine order $ 100 million according gel lin current vaccine producers contribute 15 million 20 million doses year u.s. stockpile numbers probably optimistic trial tested different concentrations antigen typical annual flu shot 45 micrograms protein covers strains influenza officials expected 30 micrograms h5n1 antigen shots 15 micrograms induce immunity preliminary trial results suggest 180 micrograms antigen